RELX (ADR)
Embeds proprietary data and analytics in professional decisions, alongside a global exhibitions business.
Something off on this page? Send us feedback.
Profile
Supplies professional data, analytics and workflow tools through Risk, Scientific, Technical & Medical, Legal and Exhibitions. Proprietary content underpins recurring digital products, while the live-events business remains dependent on in-person activity.
Provides professional information, analytics and decision tools through Risk, Scientific, Technical & Medical, Legal, and Exhibitions. LexisNexis supports legal and risk workflows, Elsevier supplies research and clinical information, and RX operates live events for customers across more than 180 countries.
Combines proprietary content and industry data with algorithms, technology and customer workflows. Acquisitions add datasets and technical capabilities, while the long-term migration from print to electronic products has made most information businesses digitally deliverable.
Recurring professional use depends on the quality and lawful use of scientific, legal, insurance, identity and public-record data. Scholarly-publishing pricing, government-data contracts and services for fossil-fuel industries remain sources of stakeholder criticism, while Exhibitions remains exposed to disruptions affecting in-person events.
Company facts
Key statistics
Year to date −8.2% · Average volume (30d) 2.5M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating |
|---|---|---|---|---|
| Apr 8, 2026 | Citigroup | Upgrade | Neutral | Buy |
| Mar 14, 2025 | Barclays | Upgrade | Equal Weight | Overweight |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026Q2 FY26 | $0.89 | $0.91 | +2.2% | $6.54B | $6.49B | −0.8% | +4.72% |
| Feb 12, 2026Q4 FY25 | $0.85 | $0.79 | −6.7% | $6.70B | $6.62B | −1.2% | +7.81% |
| Jul 24, 2025Q2 FY25 | $0.56 | $0.72 | +28.1% | $6.45B | $6.46B | +0.1% | −1.82% |
| Feb 14, 2025Q4 FY24 | $0.80 | $0.64 | −19.1% | $6.45B | $6.00B | −7.0% | −0.35% |
Financial highlights
| 12 quarters | Q4 FY23 | Q2 FY24 | Q4 FY24 | Q2 FY25 | Q4 FY25 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $6.31B | $6.28B | $6.49B | $6.42B | $6.52B | $6.64B | |
| Gross profit | $3.93B | $4.10B | $4.20B | $4.25B | $4.16B | $4.26B | |
| Operating income | $1.87B | $1.94B | $1.94B | $2.02B | $2.04B | $2.15B | |
| Net income | $1.23B | $1.33B | $1.28B | $1.32B | $1.46B | $1.60B | |
| Diluted EPS | $0.65 | $0.70 | $0.69 | $0.72 | $0.80 | $0.89 | |
| Gross margin | 62.4% | 65.3% | 64.7% | 66.3% | 63.7% | 64.1% | |
| Operating margin | 29.7% | 30.8% | 29.8% | 31.4% | 31.3% | 32.3% |
Revenue by product · FY25
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $296.0M · Total debt $11.98B · Total assets $20.22B · Shareholders' equity $1.67B
Dividends
Raised for 10 straight years. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 7, 2026 | Aug 7 | Sep 15 | $0.2785 | cut from $0.6559 |
| May 8, 2026 | May 8 | Jun 24 | $0.6559 | raised from $0.2638 |
| Aug 8, 2025 | Aug 8 | Sep 16 | $0.2638 | cut from $0.6026 |
| May 9, 2025 | May 9 | Jun 25 | $0.6026 | raised from $0.2345 split-adjusted |
| Aug 2, 2024 | Aug 2 | Sep 10 | $0.2392 | cut from $0.534 |
| May 2, 2024 | May 3 | Jun 18 | $0.534 | raised from $0.2195 split-adjusted |
| Aug 3, 2023 | Aug 4 | Sep 12 | $0.2118 | cut from $0.4661 split-adjusted |
| Apr 27, 2023 | Apr 28 | Jun 12 | $0.4833 | raised from $0.19 split-adjusted |
Ownership
Shares outstanding 1.75B · Float 1.75B · 100.0% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Capital International Investors | 8.78M | 0.50% | 13F | Aug 12, 2026 |
| Morgan Stanley | 6.57M | 0.38% | 13F | Aug 13, 2026 |
| Arrowstreet Capital, Limited Partnership | 6.28M | 0.36% | 13F | Aug 13, 2026 |
| Bank of America Corp /DE/ | 3.88M | 0.22% | 13F | Aug 14, 2026 |
| Goldman Sachs Group Inc | 3.58M | 0.20% | 13F | Aug 14, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
View detailsPeers
- Thomson Reuters
Westlaw anchors the closest legal-research and workflow rivalry
- Verisk Analytics
Insurance data and analytics across underwriting, claims, and fraud
- Clarivate
Research discovery and analytics built around Web of Science
- S&P Global
Commodity and industry intelligence through Platts and market data
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| RELX (ADR) | $36.54 | 0.00% | $63.79B | 21.3 | — | 4.8 | +0.4% |
| Thomson Reuters | $106.23 | −0.03% | $46.37B | 28.4 | 22.2 | 5.9 | +7.0% |
| Verisk Analytics | $191.77 | 0.00% | $24.96B | 29.5 | 23.5 | 8.0 | +4.4% |
| Clarivate | $2.02 | −0.25% | $1.29B | — | 2.8 | 0.5 | −5.5% |
| S&P Global | $442.90 | +0.00% | $130.56B | 27.0 | 23.4 | 8.1 | −2.1% |
| Median | 28.4 | 22.8 | 6.9 | +1.2% |